Pfizer remains a strong Buy with robust cost controls, EPS growth, and a promising pipeline, despite challenges. See more on ...

Riskified's 1Q25 results show 8% revenue growth and strong product adoption. Customer retention is robust. See why we rate ...

Traditional pathways for leaders to rise to the top C-suite job are collapsing, creating a potential leadership crisis.

The market outlook for construction and property player Kerjaya Prospek Group Bhd remains solid after the company reported a ...

GlycoEra has closed an oversubscribed Series B financing round, raising $130m, to support its lead IgG4-targeted protein ...

The opening of Universal Orlando’s Epic Universe isn’t just a boon for tourists — it’s creating career-launching ...

Eli Lilly and Company (LLY) said on Tuesday that it would acquire California-based private biotechnology company SiteOne ...

Q2 2025 Management View Victor Mendelson, Co-CEO, introduced the quarter by stating, "we are very pleased with our second quarter results, which continue to demonstrate our core business's strength ...

We recently published a list of Was Jim Cramer Right About These 11 Stocks? In this article, we are going to take a look at ...

Aberdeen businessman Toby Doeden has filed paperwork to run for South Dakota governor. Doeden chairs the Dakota First Action ...

India's North-East is fast emerging as a hotspot for new branded hotel development, with leading chains rushing in to gain an ...

Investors typically want to beat the market over the long run. Though it's not an easy task, it certainly is possible with the right companies. Let's consider two corporations that could help you do ...